SEC Comment Letter 0000000000-24-003996 to BIORA THERAPEUTICS, INC. (BIOR) (CIK 0001580063)
BIORA THERAPEUTICS, INC. (BIOR) (CIK 0001580063)
Date: April 12, 2024 · CIK: 0001580063 · Accession: 0000000000-24-003996
AI Filing Summary & Sentiment
File numbers found in text: 333-278557
Letter
United States securities and exchange commission logo April 12, 2024 Eric d’Esparbes Chief Financial Officer Biora Therapeutics, Inc. 4330 La Jolla Village Drive, Suite 300 San Diego, CA 92122 Re:Biora Therapeutics, Inc. Registration Statement on Form S-3 Filed April 8, 2024 File No. 333-278557 Dear Eric d’Esparbes: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Stewart McDowell, Esq.
Show Raw Text
United States securities and exchange commission logo
April 12, 2024
Eric d’Esparbes
Chief Financial Officer
Biora Therapeutics, Inc.
4330 La Jolla Village Drive, Suite 300
San Diego, CA 92122
Re:Biora Therapeutics, Inc.
Registration Statement on Form S-3
Filed April 8, 2024
File No. 333-278557
Dear Eric d’Esparbes:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Stewart McDowell, Esq.